These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17989185)

  • 1. Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer.
    Belousova N; Mikheeva G; Gelovani J; Krasnykh V
    J Virol; 2008 Jan; 82(2):630-7. PubMed ID: 17989185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.
    Korokhov N; Mikheeva G; Krendelshchikov A; Belousova N; Simonenko V; Krendelshchikova V; Pereboev A; Kotov A; Kotova O; Triozzi PL; Aldrich WA; Douglas JT; Lo KM; Banerjee PT; Gillies SD; Curiel DT; Krasnykh V
    J Virol; 2003 Dec; 77(24):12931-40. PubMed ID: 14645549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin.
    Krasnykh V; Belousova N; Korokhov N; Mikheeva G; Curiel DT
    J Virol; 2001 May; 75(9):4176-83. PubMed ID: 11287567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein.
    Belousova N; Krendelchtchikova V; Curiel DT; Krasnykh V
    J Virol; 2002 Sep; 76(17):8621-31. PubMed ID: 12163581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.
    Koizumi N; Mizuguchi H; Sakurai F; Yamaguchi T; Watanabe Y; Hayakawa T
    J Virol; 2003 Dec; 77(24):13062-72. PubMed ID: 14645563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells.
    Gaden F; Franqueville L; Magnusson MK; Hong SS; Merten MD; Lindholm L; Boulanger P
    J Virol; 2004 Jul; 78(13):7227-47. PubMed ID: 15194799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically targeted adenovirus vector directed to CD40-expressing cells.
    Belousova N; Korokhov N; Krendelshchikova V; Simonenko V; Mikheeva G; Triozzi PL; Aldrich WA; Banerjee PT; Gillies SD; Curiel DT; Krasnykh V
    J Virol; 2003 Nov; 77(21):11367-77. PubMed ID: 14557622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current advances and future challenges in Adenoviral vector biology and targeting.
    Campos SK; Barry MA
    Curr Gene Ther; 2007 Jun; 7(3):189-204. PubMed ID: 17584037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy.
    Han T; Tang Y; Ugai H; Perry LE; Siegal GP; Contreras JL; Wu H
    Virol J; 2007 Oct; 4():103. PubMed ID: 17958897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting.
    Lu ZH; Dmitriev IP; Brough DE; Kashentseva EA; Li J; Curiel DT
    J Virol; 2020 May; 94(10):. PubMed ID: 32102889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells.
    Dmitriev I; Kashentseva E; Rogers BE; Krasnykh V; Curiel DT
    J Virol; 2000 Aug; 74(15):6875-84. PubMed ID: 10888627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.
    Dmitriev I; Krasnykh V; Miller CR; Wang M; Kashentseva E; Mikheeva G; Belousova N; Curiel DT
    J Virol; 1998 Dec; 72(12):9706-13. PubMed ID: 9811704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.
    Kurachi S; Tashiro K; Sakurai F; Sakurai H; Kawabata K; Yayama K; Okamoto H; Nakagawa S; Mizuguchi H
    Gene Ther; 2007 Aug; 14(15):1160-5. PubMed ID: 17508008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain.
    Hesse A; Kosmides D; Kontermann RE; Nettelbeck DM
    J Virol; 2007 Mar; 81(6):2688-99. PubMed ID: 17192304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.
    Dmitriev IP; Kashentseva EA; Curiel DT
    J Virol; 2002 Jul; 76(14):6893-9. PubMed ID: 12072490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.
    Murakami M; Ugai H; Belousova N; Pereboev A; Dent P; Fisher PB; Everts M; Curiel DT
    Prostate; 2010 Mar; 70(4):362-76. PubMed ID: 19902467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-targeting ligand improves targeted transduction.
    de Vrij J; Dautzenberg IJ; van den Hengel SK; Magnusson MK; Uil TG; Cramer SJ; Vellinga J; Verissimo CS; Lindholm L; Koppers-Lalic D; Hoeben RC
    Gene Ther; 2012 Sep; 19(9):899-906. PubMed ID: 22011643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
    Stepanenko AA; Chekhonin VP
    Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.
    Stevenson SC; Rollence M; Marshall-Neff J; McClelland A
    J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.
    Campos SK; Parrott MB; Barry MA
    Mol Ther; 2004 Jun; 9(6):942-54. PubMed ID: 15194061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.